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Abstract
Functional imaging has revolutionized the neurosciences. In the pain field it has dramatically altered
our understanding of how the brain undergoes significant functional, anatomical and chemical
changes in patients with chronic pain. However, most studies have been performed in adults.
Because functional imaging is non-invasive and can be performed in awake individuals, applications
in children have become more prevalent, but only recently in the pain field. Measures of changes in
the brains of children have important implications in understanding neural plasticity in response to
acute and chronic pain in the developing brain. Such findings may have implications for treatments
in children affected by chronic pain and provide novel insights into chronic pain syndromes in
adults. In this review we summarize this potential and discuss specific concerns related to the
imaging of pain in children.
Introduction
Chronic pain
The International Association for the Study of Pain (IASP)
defines chronic pain as "an unpleasant sensory and emo-
tional experience associated with actual or potential tissue dam-
age, or described in terms of such damage" [1]. Pain is
considered chronic after 6 months of onset. However, the
majority of pain studies set the minimum time at 3
months for pain to be considered chronic. Nevertheless,
pain can be considered chronic when it does not resolve
in the expected time frame after an acute injury, and does
not respond to analgesic treatments. Chronic pain is a
common and persistent problem in adult populations
worldwide [2,3]. A recent multi-national survey study (N
= 42,249) reported a prevalence of 37.3% – 41.1% for
chronic pain conditions. Chronic pain of moderate and
severe intensity can have serious deleterious effects on the
mental health, employment status, sleep and personal
relationships of affected individuals [3,4].
Our understanding of the effect of chronic pain on corti-
cal, subcortical and brainstem neural networks has been
greatly advanced with the introduction of non-invasive
neuroimaging techniques. Pain is a subjective experience
that is not only or necessarily determined by the intensity
of the noxious stimulus [5], but also by a variety of biolog-
ical and psychosocial factors, such as sex hormones, emo-
tions, memories, or social expectations. It is therefore not
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surprising that the associated structural and functional
changes are widespread and can be observed in brain
areas not directly implicated in 'classic' pain processing.
Neuroimaging findings have fundamentally altered the
way in which we should evaluate and probably treat pain:
as a disease rather than a symptom [6] and a disease pre-
dominantly affecting the brain [7].
Brain imaging studies of chronic pain in pediatric popula-
tions offer unique opportunities to understand changes in
the young brain. Aside from providing novel insights into
CNS processing of pain in children, these studies allow
investigation of the disease from both a developmental
and neuroplastic perspective. In the pediatric population,
the brain is undergoing rapid changes, is more plastic, and
may have an increased ability to recover after injury. Cur-
rently, the long-term effects of early pain on neural sys-
tems are not well understood, but findings of early
traumatic experiences (e.g., surgery, immunization, etc)
resulting in persistent changes in CNS have been reported
[8],. Ideally, the use of non-invasive imaging methods to
objectively evaluate changes in the brain in pediatric
patients will lead to new treatment approaches that could
potentially limit the development of long-term conse-
quences.
New insights into brain function in pain
Several non-invasive imaging techniques have been
applied in research to investigate the brain areas involved
in processing of acute and chronic pain, as well as the long
term structural and functional changes occurring in the
brain of chronic pain sufferers. Most functional imaging
studies have been performed in adult volunteers or
patients. Despite the heterogeneity of the clinical pain
syndromes, a "central pain matrix" composed of primary
nociceptive areas commonly activated by painful stimuli
has been described [9]. Furthermore, additional brain
areas are involved in processing the emotional [10] and
cognitive [11] aspects of the pain experience, and their
activation is dependent on the particular set of circum-
stances for each individual [6].
Imaging studies in adults have also helped uncover the
central modulation of pain systems. By using distraction
during painful stimulation, for example, Bantick and col-
leagues [12] showed that many areas involved in pain
processing displayed reduced activation, supporting the
behavioral observations of reduced pain perception. Stud-
ies of the placebo effect also provide evidence that the
experience of pain can be altered by cortical mechanisms
[13], suggesting that the sensory experience can be shaped
by one's attitudes and beliefs [13]. The anterior cingulate
and frontal cortices are part of a descending pain modula-
tory system that exerts top-down influences on the periaq-
ueductal grey (PAG) and posterior thalamus to gate pain
modulation [14]. Other regions, including the nucleus
cuneiformis (NCF), have also been shown to be involved
in modulation of pain in human imaging studies [6,15].
If an individual can learn to control the activation of these
cortical areas through biofeedback, this might provide a
different approach to treating disease. Biofeedback using
real-time magnetic resonance imaging has been success-
fully applied in a group of chronic pain patients [16]. Sub-
jects successfully learned to control the activation of the
anterior cingulate cortex, and this process led to signifi-
cant reductions in the magnitude of experienced chronic
pain [16]. Finally, brain networks activated by empathetic
pain (observing pain in a close friend or loved one) are
similar to those activated by pain resulting from somatic
inputs in the same individual [17].
Imaging research has also contributed to our understand-
ing of the changes that occur in the brain of adult chronic
pain sufferers. The brain in chronic pain is not simply
processing heightened pain information; rather, neuronal
networks of pain-transmitting areas undergo plasticity
that results in long-term functional and structural reor-
ganization, and ultimately influence the sensory, affec-
tive, and cognitive perceptions related to pain [6,18]. The
role of the brain mechanisms in maintenance of chronic
pain is apparent in some conditions such as chronic
regional pain syndrome or fibromyalgia, in which the
pain appears to result from abnormalities of central pain
processing leading to hyperalgesia (i.e., increased
response to normal painful stimuli) and allodynia (i.e.,
pain in response to normally non-painful stimuli), rather
than from damage of peripheral structures [19]. In addi-
tion, structural imaging studies have shown that signifi-
cant atrophy is associated with chronic pain [20], raising
the possibility that chronic pain could also be considered
a degenerative disease.
Together, these studies inform our approach to therapy.
Most drugs that are currently used in the treatment of
chronic pain (opioids, antidepressants and anticonvul-
sivants) are not able to control the pain in most patients,
and in controlled clinical trials they have a ceiling effect of
approximately 30% efficacy level [20] in pooled patient
sets. In this context, neuroprotective drugs or drugs target-
ing sensory and emotional brain circuits might prove ben-
eficial. Brain imaging techniques may be useful in
monitoring the disease process and progress and the
responses to specific analgesia and experimental pain [7].
The impetus to evaluate changes in CNS function in 
children
Compared to the wealth of data from adult studies, the
research investigating brain changes in children with
chronic pain is still in its infancy. While numerous studies
have documented the increased prevalence in children ofMolecular Pain 2009, 5:30 http://www.molecularpain.com/content/5/1/30
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chronic pain conditions, such as headache, abdominal,
limb and back pain [21-23], as well as the long-term phys-
ical, psychological and social consequences of childhood
pain (see below), very few studies have addressed the
question of brain changes in pediatric pain populations.
These studies are necessary in order to understand the
effects of pain on brain maturation and plasticity proc-
esses. Indeed, many early experiences resulting in psycho-
social or physical trauma in early childhood may
eventually unfold in the form of generalized pain symp-
toms similar to those observed in depressed patients [24],
patients with fibromyalgia [25] or in patients with post-
traumatic stress disorder [26].
Chronic pain in children
Pain in children – prevalence
Prevalence rates of chronic pain in children reported in
the literature are variable, depending on the definition,
method of reporting and type of pain, as well as the char-
acteristics of the study sample (age, gender, age of onset
and duration of illness). For example, McGrath and col-
leagues [27] investigated chronic pain (defined as pain
present for more than 3 months) in children with enu-
resis, cancer, and arthritis and found that the prevalence
of chronic pain was 2.2% for enuresis, 12.5% for cancer,
and 78% for arthritis. One epidemiologic study that inves-
tigated the prevalence of chronic pain regardless of etiol-
ogy found that 25% of the 5336 children aged 4–18 years
included in the study were affected by chronic pain [23].
A survey that investigated four of the most frequent pains
(headache, stomach, back and limb pain) in a sample of
2465 adolescents aged 12–15 years revealed that 16.5%
complained of pain that occurred at least weekly; moreo-
ver, 6.5% of subjects reported having pain in more than
one location [22]. Van Dijk and colleagues [28] surveyed
495 schoolchildren aged 9 to 13 years and found that
57% of children experienced at least one recurrent pain
(headache, stomach pain, muscle pain or growing pain).
Six percent of the subjects were identified as having a his-
tory of chronic pain or having chronic pain at the time of
the study [28]. An even higher prevalence of chronic pain,
30.8% (defined as pain present for more than 6 months)
has been reported in a survey of German children and
adolescents aged 4–18 years [21]. Despite treatment, a
considerable proportion of children and adolescents con-
tinue to experience long-term pain. In a study of 254 chil-
dren and adolescents aged 0–18 years with chronic pain,
it was found that 48% of the subjects continued to experi-
ence pain one year after the original assessment, and 30%
continued to have pain at a two year follow-up [29]. There
are several methodological factors that influence the out-
come of prevalence studies in chronic pediatric pain,
related to the definition of recurrent and chronic pain,
sampling techniques and methods of data collection.
Despite the variability in the reported prevalence rates,
these studies indicate that chronic pain is a common com-
plaint in childhood and adolescence.
Chronic pain and behavior in children – long term 
consequences
Because chronic pain frequently results in higher use of
medical services and medication, it is not only an individ-
ual patient concern, but also a public health concern.
Chronic pain has a negative impact on the quality of life,
performance and mood of the affected children, and ado-
lescents and can cause social, emotional and financial
consequences for the family [30]. The severity of the pain-
associated problems experienced by children and their
families varies considerably depending on the clinical
population studied. The effect of pain on psychological
well being of children and adolescents can be substantial
and a considerable number of studies have shown that
symptoms of depression, anxiety (general and pain-spe-
cific) and stress are common complaints in children suf-
fering from recurrent childhood pain of various
etiologies, particularly when the pain is severe and causes
disability [30,31]. The prevalence of depression in 13–18
year old adolescents that experience daily pain was three
times higher (45%) than in the general population (16%)
[32,33]. In addition to the pain intensity, depression can
also be a predictor of functional disability [31] and inter-
disciplinary cognitive-behavioral treatment focusing on
disability. Children and adolescents that experience pain
are also at increased risk of missing school [32], and some
have adjustment problems related to peer rejection and
isolation [34]. These problems have been linked to aca-
demic underachievement, involvement with antisocial
peers and unemployment [35].
In addition to problems encountered during childhood,
chronic pain predisposes an individual to somatic and
psychosocial consequences that extend into adulthood,
specifically, increased reports of pain, disability and psy-
chiatric symptoms [36,37]. Infants who have major sur-
gery in the first 3 months of life show greater pain
responses and require more intra-operative pain manage-
ment during subsequent operations [38]. Even less nox-
ious stimuli, such as heel prick, can result in increased
sensitivity to mechanical stimulation lasting at least dur-
ing the first year of life [39], suggesting that abnormal
plasticity occurs in the pain pathways in the sensory con-
nections in the dorsal horn, but possibly at higher levels
in the spinal cord and even the brain. Several long-term
follow-up studies of subjects that experienced recurrent
pain during childhood found that they continue to expe-
rience pain during adulthood. For example, about 60% of
children who experienced migraine headaches during
childhood and early adolescence were still experiencing
migraines 23 years later [40], and a relatively large per-
centage of adult daily headache sufferers report the initialMolecular Pain 2009, 5:30 http://www.molecularpain.com/content/5/1/30
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onset of symptoms early in life [41]. The relative higher
impact on long-term functioning of chronic pain in child-
hood compared to adulthood is not surprising. The nerv-
ous system is more plastic during childhood to allow for
developmental and maturational processes to follow their
course. Abnormal stimuli such as recurrent pain may
affect plasticity in the peripheral and central nervous sys-
tems and may lead to long-term pain-related effects influ-
encing a wide range of functions, including nociceptive
processing, emotional processing and coping behaviors
[42]. Pediatric patients that survive severe injuries have
high incidence of post-traumatic stress disorder and
depressive symptoms in the days, weeks and months fol-
lowing hospitalization, and these symptoms are associ-
ated with long-term functional impairment and
diminished quality of life [43]. Therefore, early therapeu-
tic interventions are essential in learning adaptive rather
than maladaptive coping strategies and prevention of
long-term negative outcomes of childhood pain.
Functional imaging – opportunities for Advances
Imaging techniques – insights into functional, chemical and 
anatomical changes in the brain
A schematic of the imaging techniques used in pain
research is presented in Figure 1. Below we provide
detailed descriptions of these techniques.
Functional
Functional imaging techniques have revolutionized the
field of neuroscience research. Functional magnetic reso-
nance imaging (fMRI) is a non-invasive technique that
assesses cortical activation by measuring changes in the
local concentration of paramagnetic deoxyhemoglobin.
This method has been referred to as blood oxygen level-
dependent  (BOLD) imaging. In a BOLD experiment,
regional neuronal activation is associated with changes in
blood flow and blood volume, generally leading to a
washout of deoxyhemoglobin, which results in an
increase in local signal intensity [44]. Functional MRI
defines dynamic changes in blood flow with relatively
high spatial resolution, and is a powerful tool that can be
used to investigate neuronal networks involved in cogni-
tive processing and the effects of disease states on brain
functioning. Because it is non-invasive, fMRI can be used
repeatedly in children, therefore allowing longitudinal
studies of the development of neural networks during
childhood and adolescence, evolution of disease proc-
esses and treatment effects.
Recent fMRI studies investigating the BOLD signal in
adults have found that several brain areas show higher
activation during periods of quiet rest compared to inter-
vals when participants engage in attention demanding
cognitive tasks. These brain areas have strong functional
and anatomical connections and they form a "resting
state network" (RSN) that is consistently found across
subjects [45]. Recent studies have shown that the activity
of the "default network" is disrupted in several patholog-
ical conditions, including chronic back pain [46] and
depression [47]. Measures of the RSNs provide insight
into the functional brain connectivity during a resting
Imaging Methods used in Pain Research Figure 1
Imaging Methods used in Pain Research. See text for details.Molecular Pain 2009, 5:30 http://www.molecularpain.com/content/5/1/30
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state and have the potential to measure therapeutic effi-
cacy [7].
Cerebral near-infrared spectroscopy (NIRS) is a non-
invasive technique that can detect subtle changes in the
concentration of natural chromophores such as oxygen-
ated and de-oxygenated hemoglobin. NIRS has been suc-
cessfully applied in newborns, children and adults to
measure the hemodynamic and oxygenation changes
related to cortical processing of specific stimuli. In the
field of pain research, NIRS studies have documented that
painful stimuli elicit specific hemodynamic responses in
the somatosensory cortex, implying conscious sensory
perception in preterm neonates [48]. NIRS seems to have
a great potential in pain measures; for example, a recent
paper has indicated a specific signal for pain [49] similar
to that observed in previous fMRI studies [10].
Chemical (MRS)
Magnetic resonance spectroscopy (MRS) provides an
excellent tool to study alterations in neurotransmitters
and neuronal markers in the brain in vivo. Different types
of MRS techniques have been developed, each providing
unique information about the brain chemistry. For exam-
ple, proton spectroscopy (1H-MRS) allows measurement
of glutamate, glutamine and gamma-aminobutyric acid
(GABA), as well as N-acetyl aspartate (NAA), a neuronal
marker involved in synaptic processes [50]. Phosphorus
spectroscopy (31P-MRS) can detect phosphorus-contain-
ing compounds such as phosphodiesters, phosphomo-
noesters and phosphocreatine, which are markers of
membrane integrity and energy use in brain cells [51].
Fluoride spectroscopy (19F-MRS) allows for measure-
ments of fluorinated drug pharmacokinetics [52]. The
MRS approach has been applied in several pain condi-
tions including migraine [53] back pain [54] and spinal
cord injury [55] and it has great potential of providing
biomarkers of disease that precede structural changes in
the brain [7].
Anatomical
Diffusion Tensor Imaging (DTI) is a MRI technique that
measures changes in white matter tracts [56] based on
microstructural changes in water diffusion. Using this
approach, functional anisotropic differences in normal vs.
abnormal tracts can be inferred based on DTI measures.
The technique has been used in a number of pain disor-
ders such as migraine [57] and poststroke central pain
[58] and may offer insights into the underlying changes in
brain state. Although there are some limitations to DTI
[59], when combined with fMRI studies, it may help
improve our understanding of functional anatomical
mapping of processing information.
Information about structural and functional organization
of the brain can also be inferred from MRI data. Cortical
thickness measurements reflect the size, density, and
arrangement of neurons, glial cells and nerve fibers.
Recent studies have shown that regions that are axonally
connected have strongly correlated cortical thickness
measurements, possibly reflecting the underlying cytoar-
chitecture and neural connectivity [60]. Therefore, analy-
ses of the whole-brain cortical thickness data allow
identification of large-scale anatomical networks, provid-
ing a different method to investigate the normal cerebral
development and cortical abnormalities in various neu-
ropsychiatric disorders, as well as validate the findings of
functional networks studies [61].
Imaging children – concerns and considerations
Magnetic resonance imaging is non-invasive and can be
used repeatedly in children, therefore allowing longitudi-
nal studies of the development of neural networks during
childhood and adolescence, evolution of disease proc-
esses and treatment effects. Functional magnetic reso-
nance imaging (fMRI) is a powerful tool that can be used
to investigate neuronal networks involved in cognitive
processing and the effects of disease states on brain func-
tioning.
Ethical considerations
The Nuremberg Code and the Helsinki Declaration were
among the first documents to establish principles of
proper and responsible conduct of human experimenta-
tion in medical research. The Belmont Report (National
Commission for the Protection of Human Subjects of Bio-
medical and Behavioral Research, 1978) provided basic
ethical principles that should govern research involving
human subjects and supported the protection of vulnera-
ble populations. The three fundamental ethical principles
outlined in the Belmont report are respect, beneficence and
justice, and the interpretation of these principles is differ-
ent in pediatric vs. adult populations. Respect refers to the
recognition and protection of the autonomy of all indi-
viduals. Certain vulnerable populations have reduced
autonomy because of young age, illness, mental disabil-
ity, or situations that restrict their liberty and have
impaired ability to provide free informed consent. In
these situations, the appropriate level of protection is a
matter of balancing the principle of respect for persons
with the need to protect vulnerable populations [62]. In
addition to obtaining consent from the parents, children
who have the intellectual maturity should be given the
opportunity to assent (or dissent) to participating in
research.
The beneficence principle refers to maximizing the benefits
obtained from research while minimizing risks to the
research subjects. Under US regulations, InstitutionalMolecular Pain 2009, 5:30 http://www.molecularpain.com/content/5/1/30
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Review Boards (IRBs) can approve pediatric research that
falls within one of 3 categories: (1) minimal risk, (2) more
than minimal risk with the prospect of direct benefit and
(3) minor increase over minimal risk and no direct bene-
fit, but likely to generate important scientific knowledge
[63]. To be ethically acceptable, the risk/benefit profile
should be at least as favorable to the subject as the availa-
ble alternative, including not participating in research
[63]. Related to the risk of participating in research, the
use of placebo trials in children has been controversial,
because doing so might unnecessarily expose children to
undue risk of physical or psychological pain and discom-
fort [64]. Instead, using an alternate therapy has been con-
sidered an acceptable solution. The benefits of research
are broader than the individual direct benefit from a drug
or procedure being investigated. Benefits include addi-
tional medical attention, and any physical or psychologi-
cal tests a subject might receive as part of the research
protocol. In addition, other children will benefit from
medical advances that result from research. These bene-
fits, as well as the risks associated with not doing research
in children should all be considered when evaluating the
risk/benefit profile of research studies [64]. The justice
principle refers to the fairness of subject selection and
equal treatment of all subjects. Because research carries
both benefits and burdens, justice requires that no one
socio-economic group receive disproportionate benefits
or bear disproportionate burdens related to research. The
NIH now requires that children must be included in all
research studies supported by NIH, unless there are scien-
tific and ethical reasons not to include them.
In the area of pediatric pharmacotherapy, protection meant
excluding children from research. As a result, only about
20% of the drugs prescribed for children have been sys-
tematically tested for their safety and efficacy in pediatric
populations [64]. Recently, legislative changes have led to
an increased number of studies conducted in children.
The Food and Drug Administration (FDA) can require
companies submitting a new drug application to test the
drug in children if pediatric use is anticipated, and the
National Institute of Health (NIH) can offer contracts to
fund studies in pediatric populations. Rather than restrict-
ing pediatric research because of the inherent challenges,
it is important to allow children to participate in well-
designed research studies so that they can benefit from
research advances to the same degree as adult popula-
tions.
Growing brain – maturation of systems/processes
Human brain development is a non-linear process in
which structural and functional maturation continue into
early adulthood [65]. The brain areas associated with
basic functions mature early (i.e., motor and sensory cor-
tices and parietal areas involved in spatial orientation,
speech and attention), while the frontal areas involved in
higher functions (i.e., executive processing, attention,
motor coordination) mature more slowly. Brain growth
occurs most robustly during the first 3 years of life and
brain weight reaches adult values (about 1.45 kg) between
10 and 12 years of age [66]. The increase in brain volume
during the first three years of life reflects an increase in
gray matter (i.e., development of dendritic trees and syn-
aptogenesis) as well as fiber tract myelination [67,68].
The ratio of gray to white matter volume changes with age:
gray matter increases until about age 8 and then decreases,
while white matter increases until about age 30 before
starting to decrease [69,70]. At the neuronal level, den-
dritic development and synaptogenesis occur in subcorti-
cal and cortical structures at different rates and at different
ages. For example, synaptogenesis starts between 3 and 4
months of age in the visual and prefrontal cortices, but
while the process is rapid and maximum synaptic density
is reached between 4 and 12 months in the visual cortex,
the development of synapses is slower in the prefrontal
areas, where maximum synaptic density is reached around
1–2 years postnatally [68]. Significant reductions in the
number of neurons through the process of programmed
cell death (e.g., apoptosis) and pruning of synapses also
occur during development in many brain areas, including
visual cortex, medial amygdala, nucleus accumbens and
the hypothalamus [71,72]. In the prefrontal cortex synap-
tic density decreases between two and six years of age and
reaches adult levels by sixteen years of age [72].
The pattern of age-related neuroanatomical changes is
paralleled by physiological changes. Cerebral metabolic
rates are closely linked to the synaptic activity of cortical
neurons. The overall resting activity of the gray matter
regions as measured by glucose utilization using positron
emission tomography (PET) is low at birth, increases after
the first year of life and reaches a peak around four or five
years of age [73]. At their peak, the metabolic levels are
higher than adult levels, and are maintained until approx-
imately nine years of age, subsequently decreasing to
reach adult levels by the latter part of the second decade of
life [73]. However, different cortical areas have different
rates of functional maturation. The sensory-motor cortex,
thalamus, brainstem, and cerebellar vermis are the first
areas to show increases in glucose uptake, followed by the
parietal, temporal, occipital and cerebellar cortices, and
finally by the frontal and dorsolateral occipital cortices
[65].
The plastic brain
Increased synaptic density in the developing brain pre-
sumably reflects the number of unspecified or labile syn-
aptic contacts and provides the anatomical substrate for
plasticity [68]. Critical periods are specific developmentalMolecular Pain 2009, 5:30 http://www.molecularpain.com/content/5/1/30
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windows when genetic and environmental processes
interact to establish normal long-term functionality.
Genetic or environmental insults occurring during these
critical periods could lead to abnormal structural and
functional rearrangements of the cerebral cortex. For
example, increased alcohol consumption during adoles-
cence can result in decreased volume of the prefrontal cor-
tex and prefrontal cortex white matter [74]. From a
therapeutic perspective, critical periods could allow for
normalization of impaired functions. One striking exam-
ple relates to the visual system: strabismic amblyopia can
be reversed during childhood, provided that the good eye
is occluded and the child is forced to use the squinting eye
[68].
Plasticity is not limited to periods of brain development.
The strength of synapses changes as a function of neuro-
nal activity (i.e., activity-dependent plasticity) so that
coherence of functional networks (or "cell assemblies")
can either increase or decrease as a result of persistent syn-
aptic activity. Activity-dependent plasticity in pain circuits
has been proposed as a mechanism that may lead to a pro-
gressive increase in the response of the system to repeated
stimuli [75]. In the peripheral nervous system (PNS),
activity-dependent plasticity manifests itself through
decreased threshold of the nociceptor terminals, and
increased release of neuromodulators in the circuits of the
dorsal horn [75]. The nociceptive pathways can exhibit
reversible changes in the excitability of primary sensory
and central neurons ("modulation"), as well as long-last-
ing alterations related to synthesis of neurotransmitters,
expression of receptors and ion channels, or connectivity
and survival of neurons in the network ("modification")
[75]. These changes in the dynamics of neural networks
could be related to pain behaviors, and could explain
increased pain sensitivity to various stimuli (i.e., thermal
and mechanical allodynia and hyperesthesia) in chronic
pain sufferers [46]. Pain-induced plasticity can persist
after the painful stimulus ceases and pain becomes a
maladaptative process.
Morphing brains
Adult brains vary in shape and size between individuals.
In order to analyze and interpret data from neuroimaging
studies, researchers often perform spatial transformations
on each subject's brain into a common anatomical frame
of reference, either Talairach space (based on a single sub-
ject's brain [76] or, more recently, on population-based
atlases such as the MNI305 atlas [77]. Non-linear spatial
transformations have also been applied to imaging data,
increasing the quality of inter-subject registration and
allowing improved anatomical localization of BOLD acti-
vation [78,79].
In addition to the problems raised by performing transfor-
mations to a standard space, analysis of MR imaging data
from children poses additional challenges. Firstly, child
brains are more variable than adult brains and variability
seems to be increased in children younger than six years
of age [80]. Secondly, the size of the brain is smaller in
children than in adults, but a child brain is not simply a
reduced adult brain because complex maturational proc-
esses occur at different rates in different brains structures,
as described earlier. Transforming pediatric brains into an
adult-derived space by simple proportional downsizing of
a grid system is likely to introduce additional bias into the
analysis of fMRI data from young subjects. The bias is
likely to be larger in data from children younger than 6
years, for smaller brain structures (such as the brainstem
or subcortical regions), and for higher-resolution images
[80,81]. To date, there are no pediatric brain atlases. In
1999, the National Institute of Neurological Disorders
and Stroke (NINDS) initiated the Pediatric Neuroana-
tomic Study, a multicenter program that aims to establish
a normative neuroimaging database for brain develop-
ment in healthy children (0–18 years). It is expected that
this study will provide data that can be used to generate
age-specific brain atlases, which will greatly facilitate fur-
ther advances of neuroimaging research in children. How-
ever, Burgund and colleagues [82] examined the
variability of various brain regions in children aged 7–8
years (transformed into stereotactic space), and found
that they differed only slightly from adults, thus validating
the use of a standard, adult atlas in this pediatric popula-
tion.
Blood-oxygen-level dependent (BOLD) signal
Similar to the inherent biases encountered when scaling
pediatric brains to adult atlases, statistical thresholds used
in pediatric research to identify signal changes are derived
from adult studies and might not readily apply to data
acquired from children. Identifying true activation in
young subjects might be biased in the presence of differ-
ences in threshold of response, reactivity, or robustness of
the response between pediatric and adult populations. For
example, Thomason and colleagues [83] examined breath
holding fMRI responses in children younger than 12 years
of age and adults and found that the BOLD response is
smaller and noisier in children than in adults, conse-
quently producing less significant activation maps. Dur-
ing the early stages of development of different cortical
areas, gray matter has a greater thickness and density in
children compared to adults. For brain areas such as the
prefrontal cortex that develop slowly, these differences are
maintained until adolescence. Therefore, the magnitude
of the signal acquired from gray matter areas should be
corrected for volume averaging effect, and the correction
should take into account the age of the subjects and the
cortical area under investigation.Molecular Pain 2009, 5:30 http://www.molecularpain.com/content/5/1/30
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Several fMRI studies showed that children under the age
of five have variable patterns of BOLD signal changes
when compared to adults [84]. While adults show consist-
ent positive BOLD responses in the occipital cortex in
response to visual stimulation, children can have either
positive or negative BOLD signal changes [85], suggesting
that in young children the hemodynamic coupling may
be different than in adults. However, after 8 years of age,
the hemodynamic response functions are similar to the
adult population [86]. The interpretation of these imaging
studies is difficult because most of the young children
were sedated, which has been shown to reverse the direc-
tion of the BOLD signal in adults [87]. In awake infants
(aged three days to fourteen weeks old) investigated with
near infrared spectroscopy, the increase in oxygen con-
sumption in the visual cortex after visual stimulation out-
paces the increase in blood flow, supporting the
observation that the hemodynamic response in children is
a reversal of the adult pattern [88].
Taken together, these studies underscore that special con-
sideration has to be given to methodological factors when
analyzing and interpreting fMRI data from infants and
young children.
Imaging pain
Overview of pain imaging studies- adults
A recent meta-analysis of human studies of acute pain
described a neural network composed of several areas that
are consistently activated during pain perception. This
network, sometimes termed the "pain matrix", included
the thalamus, primary (S1) and secondary (S2) somato-
sensory cortices, insula, anterior cingulate cortex (ACC)
and the prefrontal cortex (PFC) [89]. The activity of the
pain matrix decreases during pharmacologically induced
analgesia [90]. These areas perform parallel processing of
the different aspects of pain. While thalamus, S1, S2 and
parts of insula process the sensory-discriminative features
of the painful stimulus (i.e., stimulus localization and
intensity), the ACC and anterior insula process the affec-
tive-motivational aspects (emotion, arousal, selective
attention) and the PFC responds to the cognitive aspects
of pain (attention, memory, stimulus evaluation) [91,92].
The signature of chronic pain on the brain is partially dis-
tinct, and includes not only the pain matrix, but also brain
regions critical for cognitive and emotional processing,
such as the medial prefrontal cortex (mPFC), dorsolateral
prefrontal cortex (DLPFC), parietal association cortex,
amygdala, ventral striatum, and hippocampus [93,94].
Imaging studies have shown that reorganization occurs in
several brain areas involved in sensory and affective
processing of pain, such as the thalamus and the cortex.
One study investigating patients with chronic back pain
(lasting more than 6 months) showed regionally specific
decreased gray matter volume in bilateral dorso-lateral
prefrontal cortex (DLPFC) and right thalamus [95] sug-
gesting that the pathophysiology of chronic pain includes
thalamo-cortical processes. Both DLPFC and thalamus are
involved in perception of pain, and DLPFC has been
hypothesized to inhibit the orbitofrontal cortex (OFC),
therefore decreasing the intensity of perceived pain [96].
The thalamus is an important relay in the nociceptive and
sensory pathways from the spinal cord to the cortex and
decreased thalamic gray matter may be related to the gen-
eralized sensory abnormalities associated with chronic
pain [97]. One recent study [93] has shown that chronic
spontaneous pain is associated with increased activation
of the mPFC, a region involved in detection of unfavora-
ble outcomes and processing negative emotions and
response conflict [98]. Other studies also described
reduced gray matter in brain areas related to pain sensa-
tion, memory, and associated emotional processing, such
as the anterior cingulate cortex (ACC), anterior and poste-
rior insula, orbito-frontal cortex, and parahippocampus
[20,99,100]. Taken together, these studies support the
idea that chronic pain may lead to structural changes in
cortical and subcortical brain areas.
Further evidence for pain-related changes in the brain is
provided by studies investigating brain chemistry. N-
acetyl aspartate (NAA) is a neuronal marker involved in
synaptic processes [50]. Decreased levels of NAA in the
brain may reflect neuronal loss and degeneration, as well
as long-term neurotransmitter changes. Grachev and col-
leagues [101,102] showed decreased levels of NAA in the
DLPFC in patients with chronic low back pain or CRPS.
Similarly, Sorensen and colleagues [103] found that
patients with neuropathic diabetic pain have reduced
NAA levels in the thalamus compared to diabetic patients
without pain.
Results from functional studies using positron-emission
tomography (PET) or fMRI suggest that brain function
may be affected by chronic pain. Von-Frey stimulation of
the affected limb in adult patients with CRPS evoked pin-
prick hyperalgesia and produced greater contralateral acti-
vation than identical stimulation of the unaffected limb
in primary (S1) and secondary (S2) sensory cortex, insula,
anterior cingulate cortex, and frontal cortices [104,105].
Mechanical allodynia evoked by brushing the affected
limb was reported to correspond with activation of motor
(M1) and cognitive regions (frontal regions), areas
involved in emotional processing (e.g., anterior and pos-
terior cingulate cortex, temporal lobe), parietal associa-
tion cortices, as well as pain sensory regions (e.g., S1,
insula) [104]. Of note was the significant negative activa-
tion in visual, posterior insular, and temporal cortices in
response to brushing that evoked allodynia. In a recent
study using magnetic source imaging, cortical reorganiza-Molecular Pain 2009, 5:30 http://www.molecularpain.com/content/5/1/30
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tion was reported in the contralateral S1 cortex in patients
with CRPS [105]. The reorganization involved parts of the
body (lips and fingers) that did not have pain, but
exchanged representations following recovery from CRPS.
Functional cortical reorganization has also been described
after limb amputation in primary somatosensory and
motor cortices [106], and it has been related to phantom
limb pain, rather than referred phantom sensations [18].
Cortical reorganization in patients with phantom limb
pain also occurs in brain areas involved in processing
affective-motivational aspects of pain, such as the insula,
anterior cingulated cortex, and frontal cortices [107].
Taken collectively, these studies suggest that cortical plas-
ticity in adults suffering from chronic pain is intrinsically
maladaptive, particularly with respect to sensory-motor
processing and that such changes are an essential feature
underlying the pathophysiology of the disease.
During performance of cognitive tasks, the RSN shows
functional reorganization and at least three canonical net-
works emerge. The "default-mode network" (DMN) is
composed of brain regions that show decreases in activa-
tion and includes the ventromedial prefrontal cortex
(VMPFC) and posterior cingulate cortex (PCC)
[45,46,108]. Other emerging networks typically show
increases in activation during cognitive tasks, including
the central-executive network, which includes the DLPFC
and posterior parietal cortex (PPC), and the salience net-
work, which includes the ventrolateral prefrontal cortex
(VLPFC), anterior insula, and the anterior cingulate cortex
(ACC) [109,110]. Baliki and colleagues [46] showed that
the functional connectivity within the DMN is altered in
patients that had suffered from chronic back pain for an
average of 6 years. Compared to healthy control subjects,
patients with chronic back pain exhibited decreased deac-
tivation in the mPFC, amygdala, and PCC during per-
formance of an attention task. The extent of the mPFC
deactivation was correlated with the number of years of
pain suffering. In this study, performance on the attention
task was similar between chronic pain and control sub-
jects, suggesting that the differences in DMN connectivity
were not related to the ability to complete the task. This
study supports the idea that chronic pain has a wide-
spread effect on brain function, affecting cortical circuits
beyond those involved in perception. A second study
investigated RSNs in female patients with complex
regional pain syndrome and found increased connectivity
between nodes of the salience network, including the
bilateral insula and temporal pole, the bilateral cerebel-
lum, and the left sensory-motor cortex; no changes were
found in the vision-related network or the DMN between
patients and healthy controls [111]. In this study, the pain
severity was correlated with bilateral insular and temporal
pole connectivity, whereas the duration of pain was corre-
lated with dorsal anterior cingulate and hypothalamus/
thalamus connectivity, suggesting that the brain changes
are a consequence, rather than a cause of the increased
nociceptive perception [111]. While these two studies
report contradictory results in relation to the changes in
DMN in chronic pain, it is important to note that brain
reorganization is a plastic, time-dependent process that is
initially driven by peripheral and spinal cord events, and
subsequently by higher processing related to coping strat-
egies [46]. Therefore, it is likely that the extent and the pat-
tern of functional alteration in the DMN are related to the
duration of chronic pain, as well as other pain character-
istics (intensity and type of pain, presence of depression
or anxiety).
In summary, findings from structural and functional
imaging studies in humans suggest that the brain in
chronic pain is not simply processing heightened pain
information. The network of pain-transmitting areas
within the central nervous system undergoes functional
and structural reorganization in patients with chronic
pain, and this central plasticity could in turn influence the
sensory, affective, and cognitive perceptions related to
pain.
Pain imaging studies in children
Acute pain studies
Somatosensory-evoked potential studies have shown that
from at least the 7th gestational month, the somatosen-
sory pathways can conduct peripheral impulses to the cor-
tex and the cortex is mature enough to produce responses
[112]. As the pathways become myelinated during normal
development, the latencies of the cortical responses
decrease [113]. However, very little is known about cen-
tral pain processing in infants and young children.
Because the brain development and maturation continues
after birth, and the affective and cognitive circuits are not
fully developed in young children, it is likely that the pain
experience has different dimensions in pediatric popula-
tions compared to adults. It is possible that the brain
responses to the painful stimuli are also different in chil-
dren.
To date, only two NIRS studies investigated brain changes
during acute pain experiences in children. Slater and col-
leagues [114] measured changes in cerebral oxygenation
over the somatosensory cortex in premature infants
undergoing heel lances for routine blood sampling. The
results showed that infants aged between 25 and 45 weeks
gestational age exhibited clear cortical responses in the
contralateral somatosensory cortex, and that the magni-
tude increased while the latency of the response decreased
with age. A similar increase in the hemodynamic response
in the somatosensory cortex has been described by Bar-
tocci and colleagues [48] in preterm newborns (28–36
weeks of gestation) during venipuncture. In their study,Molecular Pain 2009, 5:30 http://www.molecularpain.com/content/5/1/30
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somatosensory cortical activation was bilateral, and no
increase in activation was observed in the parietal and
occipital cortices, suggesting that preterm newborns
might be consciously processing acute pain.
Chronic pain studies
To date, only one study has been published on brain
changes in children with chronic pain. Using fMRI, Lebel
and colleagues [115] investigated children nine to eight-
een years of age with CRPS affecting the lower extremity.
Unlike adult CRPS, the pain in pediatric CRPS frequently
fluctuates and often resolves in less than 2 years, allowing
comparisons of painful vs. pain-free states. Patients
underwent two scanning sessions: the first one during an
active period of pain, and the second one after sympto-
matic recovery. During active CRPS, patients experienced
mechanical and thermal allodynia for the affected extrem-
ity, and BOLD activation patterns were similar to data
reported in adults [104]. Activation changes were
observed in pain-related areas (primary sensory-motor
cortices, insula) and also in regions that presumably con-
tribute to non-pain symptoms. These included the pari-
etal, frontal and temporal cortices, which are thought to
be involved in attention and other aspects of altered cog-
nition, fear and anxiety [104,116]. Interestingly, the brain
activation patterns continued to be different in response
to mechanical and thermal stimulation of the affected vs.
unaffected extremity, despite the absence of allodynia,
suggesting that functional abnormalities in CNS circuitry
may outlast the signs and symptoms of CRPS and could
alter the pain processing later in life.
Conclusion and future directions
The prevalence of chronic pain in children warrants fur-
ther research to decipher the mechanisms of pain and
potential therapeutic approaches. Research in children
presents special challenges related to ethical treatment of
children, technical adaptations necessary for acquiring
and analyzing data, and interpretation of results from a
developmental perspective.
Functional imaging of the changes that occur in the devel-
oping brain as a consequence of chronic pain experience
is still an emerging field, and there is a considerable
amount of information that we could learn from these
studies. First, functional imaging studies during resting
states or during peripheral stimulation of nociceptive
pathways are essential in characterizing the brain net-
works that are modified by pain and the effects of affective
and cognitive processing on these networks. Second, ana-
tomical imaging studies can aid in uncovering the connec-
tivity between nodes of the functional networks and
provide insight into the cause of functional changes.
Third, the investigation of chemical changes in the brain
provides another approach for characterizing the CNS
changes in chronic pain and may allow investigation of
drug pharmacokinetics at target sites in the brain [52].
Because these techniques are non-invasive, they can be
used repeatedly in longitudinal designs in order to assess
the long-term changes in brain structure and function,
and the effect of pain on normal development and matu-
ration. Fourth, imaging methods could be useful in evalu-
ating the response to therapy and could help development
of new approaches in clinical trials.
The directions outlined above are essential in understand-
ing the changes in neural systems produced by chronic
pain, from an anatomical and functional level to human
behavior and long-term effects on fundamental develop-
mental and maturational processes.
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